# Nutrasource

confirmed via its own domain's case coverage of advancing CBD innovation through regulatory-strategy-to-clinical-execution work with DSM-Firmenich, and independent Nutritional Outlook coverage of how the SGS Nutrasource brand serves the industry through certifications, clinical trials, and consumer-trust practice.

Source: https://en.bioecon.ru/companies/nutrasource/
Updated: 2026-08-21

- Country: Canada

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | approximately CAD 20 million (2022-12-31) | https://www.sgs.com/en-hk/news/2023/05/sgs-acquires-a-majority-stake-in-nutrasource |
| Headcount | over 150 employees worldwide (2023-05-11) | https://www.nutrasource.ca/about/our-story/, https://www.sgs.com/en-hk/news/2023/05/sgs-acquires-a-majority-stake-in-nutrasource |
| Production site | four sites in North America (2023-05-11) | https://www.nutrasource.ca/about/our-story/ |
| Certification | NutraStrong, IFOS, IGEN, IPRO, ICAP, IKOS, IAOS, and Radioactivity Tested & Certified programs | https://www.nutrasource.ca/, https://www.sgs.com/en-hk/news/2023/05/sgs-acquires-a-majority-stake-in-nutrasource |
| Regulatory approval | Institution-wide Cannabis Research Licence and Controlled Drugs and Substances Dealer’s Licence from Health Canada | https://www.nutrasource.ca/resources/news/health-canada-approval-for-institution-wide-cannabis-research-licence/, https://www.nutrasource.ca/resources/news/health-canada-approves-nutrasources-expanded-research-capabilities-in-controlled-drugs-and-substances/ |
| Funding | Majority stake acquired by SGS in 2023 [medium confidence] | https://www.sgs.com/en-hk/news/2023/05/sgs-acquires-a-majority-stake-in-nutrasource |

Independent sources: sgs.com

## Technologies

- [Health-claim substantiation (EFSA 13/14)](https://en.bioecon.ru/technology/health-claim-substantiation-efsa/)